Xingang Pharmaceutical Sustainability Profile
Xingang Pharmaceutical Co., Ltd., commonly referred to as Xingang Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 2001, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of generic drugs and active pharmaceutical ingredients (APIs). With a strong operational presence across Asia and expanding into global markets, Xingang Pharma is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of medications that cater to various therapeutic areas, setting them apart through rigorous quality control and adherence to international standards. Xingang Pharma has achieved notable milestones, positioning itself as a trusted name in the industry, and continues to enhance its market presence through strategic partnerships and a focus on research and development.
DitchCarbon Score
How does Xingang Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Xingang Pharmaceutical's score of 15 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Xingang Pharmaceutical's reported carbon emissions
Xingang Pharmaceutical, headquartered in CN, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Xingang Pharmaceutical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Xingang to consider setting measurable targets and reporting their emissions to align with global climate goals.
How Carbon Intensive is Xingang Pharmaceutical's Industry?
How Carbon Intensive is Xingang Pharmaceutical's Location?
Xingang Pharmaceutical's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Xingang Pharmaceutical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
